27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
- Penumbra Inc (NYSE:PEN) and Japan-based medical device manufacturer Asahi Intecc Co will collaborate to introduce Penumbra's Indigo Aspiration System into the Japanese market upon regulatory approval.
- The Indigo Aspiration System can be used to remove emboli and thrombi from peripheral arterial and venous systems vessels and treat pulmonary embolism.
- Indigo is a minimally-invasive device that enables blood flow restoration in cases such as acute limb ischemia and venous thrombus.
- Related: Citing' Lightning Fast Growth,' Needham Upgrades This Vascular Device Company.
- The newer generation device combines hypotube-based Indigo Aspiration Catheters with Lightning Intelligent Aspiration, a computer-aided clot detection technology that can differentiate between clot and blood, designed to reduce blood loss and the need for clot-dissolving drugs.
- Penumbra's neurovascular thrombectomy and neurovascular and peripheral embolization devices will continue to be distributed by its long-time partner, Medico's Hirata.
- Price Action: PEN shares are down 2.79% at $180.83 on the last check Thursday.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!